CN Stock MarketDetailed Quotes

002294 Shenzhen Salubris Pharmaceuticals

Watchlist
  • 33.97
  • -0.21-0.61%
Market Closed Dec 13 15:00 CST
37.87BMarket Cap61.99P/E (TTM)

Shenzhen Salubris Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
-42.31%1.03B
-50.61%938.24M
-39.24%1.41B
-50.50%1.32B
-44.64%1.78B
-46.00%1.9B
-31.83%2.33B
-17.47%2.67B
-2.66%3.22B
3.08%3.52B
Transactional financial assets
195.70%667.58M
158.10%533.82M
-58.29%180.74M
-43.34%186.06M
220.71%225.76M
588.52%206.83M
377.85%433.29M
447.27%328.36M
75.51%70.39M
24.94%30.04M
Notes receivable and accounts receivable
5.94%485.36M
-12.89%534.68M
-15.69%470.27M
-6.51%467.4M
-13.39%458.15M
21.91%613.78M
17.32%557.77M
25.59%499.97M
4.56%529M
-2.59%503.49M
-Notes receivable
----
----
----
----
----
----
----
----
-87.33%8.49M
-78.71%12.72M
-Accounts receivable
5.94%485.36M
-12.89%534.68M
-15.69%470.27M
-6.51%467.4M
-11.98%458.15M
25.07%613.78M
18.68%557.77M
26.39%499.97M
18.58%520.52M
7.36%490.76M
Other receivables (including interest and dividends)
63.53%33.35M
65.65%31M
28.08%29.08M
-10.24%21.01M
21.99%20.4M
30.31%18.71M
-84.86%22.71M
-84.95%23.4M
-21.98%16.72M
-42.78%14.36M
-Other receivable
----
65.65%31M
----
----
----
30.31%18.71M
----
-84.95%23.4M
----
-42.78%14.36M
Advance payment
98.19%43.72M
-36.99%27.46M
62.52%54.55M
-23.46%26.13M
-18.03%22.06M
86.22%43.59M
33.86%33.56M
157.65%34.13M
11.34%26.91M
-29.92%23.41M
Inventories
3.10%487.88M
-3.53%471.82M
-13.16%457.28M
-9.69%490.86M
1.92%473.19M
-0.98%489.06M
16.28%526.58M
29.27%543.53M
22.13%464.29M
19.28%493.9M
Receivable financing
-11.08%111.2M
17.06%85.75M
59.81%179.45M
35.05%77.98M
55.28%125.06M
233.13%73.25M
-13.34%112.29M
-23.94%57.74M
--80.54M
--21.99M
Assets held for sale
----
----
----
----
0.00%11.73M
0.00%11.73M
0.00%11.73M
0.00%11.73M
-91.94%11.73M
-91.93%11.73M
Non-current assets due within one year
--214.76M
----
--164.61M
--163.33M
----
----
----
----
----
----
Other current assets
19.26%689.37M
21.28%689.85M
0.38%548.62M
3.03%558.49M
1,848.23%578.06M
3,097.45%568.82M
1,507.73%546.53M
1,541.84%542.07M
-52.63%29.67M
-70.63%17.79M
Total current assets
1.76%3.76B
-15.61%3.31B
-23.47%3.5B
-29.68%3.31B
-16.89%3.7B
-15.31%3.93B
-4.42%4.57B
6.98%4.71B
-0.86%4.45B
0.05%4.64B
Non Current assets
Other equity investment
12.78%264.8M
0.00%234.8M
0.00%234.8M
17.40%234.8M
17.40%234.8M
17.40%234.8M
17.40%234.8M
0.00%200M
0.00%200M
0.00%200M
Other non-current financial assets
-0.73%276.08M
21.46%277.43M
22.75%276.41M
22.07%276.38M
21.30%278.1M
1.19%228.41M
1.13%225.18M
1.48%226.42M
4.83%229.27M
3.24%225.72M
Investment real estate
-9.82%32.49M
-1.71%32.9M
11.28%35.19M
-6.87%32.35M
-17.89%36.03M
-5.58%33.48M
-5.55%31.62M
21.38%34.73M
52.66%43.88M
29.00%35.46M
Long-term equity investment
-0.29%282.64M
-4.02%280.44M
-3.54%283.97M
-2.35%290.74M
2.66%283.46M
5.43%292.18M
5.63%294.39M
6.83%297.73M
18.51%276.11M
7.87%277.12M
Fixed assets
----
-2.08%1.37B
----
----
----
-5.26%1.4B
----
-5.79%1.44B
----
22.60%1.48B
Constru in process
----
-15.62%50.62M
----
----
----
31.95%59.99M
----
-60.06%37.6M
----
-88.23%45.47M
Intangible assets
4.81%1.42B
-8.88%1.26B
36.52%1.26B
36.52%1.32B
37.59%1.35B
40.18%1.39B
-6.92%922.9M
-7.92%965.46M
-19.04%982.45M
-19.30%988.38M
Development expenditure
25.22%1.44B
43.57%1.5B
6.46%1.39B
6.45%1.3B
-3.76%1.15B
-5.59%1.04B
18.73%1.31B
26.65%1.22B
31.77%1.2B
26.70%1.1B
Goodwill
-81.97%10.91M
-81.97%10.91M
-81.97%10.91M
-81.97%10.91M
-30.54%60.53M
-30.54%60.53M
-30.54%60.53M
-30.54%60.53M
0.00%87.14M
0.00%87.14M
Long deferred expense
-3.22%105.7M
-7.38%104.1M
-4.56%112.34M
-5.43%117.98M
-12.77%109.22M
-13.95%112.39M
-10.92%117.71M
47.50%124.75M
35.01%125.2M
66.47%130.61M
Deferred tax assets
78.07%131.42M
31.51%116.2M
7.41%93.96M
-1.15%87.4M
-9.10%73.8M
5.65%88.36M
-6.01%87.48M
7.81%88.42M
15.36%81.19M
41.45%83.63M
Usufruct assets
-43.31%18.85M
-40.77%14.91M
-31.86%18.11M
-28.91%20.83M
-19.13%33.25M
99.25%25.18M
84.70%26.58M
81.29%29.3M
191.54%41.11M
-0.65%12.64M
Other non current assets
61.77%1.07B
75.33%1.08B
195.32%960.37M
199.12%959.68M
112.97%661.84M
181.82%613.21M
58.12%325.2M
54.89%320.83M
353.47%310.77M
135.30%217.59M
Total non current assets
12.86%6.47B
13.46%6.33B
19.85%6.11B
20.61%6.08B
12.87%5.73B
14.14%5.58B
3.75%5.1B
4.21%5.04B
6.58%5.08B
3.49%4.89B
Total assets
8.51%10.23B
1.45%9.64B
-0.63%9.61B
-3.68%9.4B
-1.02%9.43B
-0.20%9.5B
-0.28%9.67B
5.53%9.76B
2.97%9.53B
1.79%9.52B
Liabilities
Current liabilities
Short term loan
-68.36%60M
-94.88%10M
-83.48%10M
-77.42%40M
18.44%189.61M
-14.51%195.38M
-66.43%60.55M
181.25%177.19M
38.58%160.09M
-0.72%228.54M
Transactional financial liabilities
----
----
----
----
----
----
--2.21M
--1.87M
----
----
Notes payable and accounts payable
1.78%131.24M
6.02%145.72M
-19.69%163.24M
-28.97%156.01M
-38.86%128.94M
-27.02%137.44M
1.04%203.26M
17.04%219.65M
2.94%210.91M
42.47%188.32M
-Notes payable
----
----
----
----
----
----
--35.31M
--33.57M
--40M
----
-Accounts payable
1.78%131.24M
6.02%145.72M
-2.80%163.24M
-16.16%156.01M
-24.55%128.94M
-27.02%137.44M
-16.51%167.95M
-0.85%186.08M
-16.58%170.91M
42.47%188.32M
Contract liabilities
-35.79%31.78M
-12.34%39.79M
-41.46%31.26M
-31.06%29.41M
-42.51%49.5M
-43.67%45.39M
-24.81%53.4M
-56.46%42.66M
-3.47%86.09M
13.83%80.58M
Advance receipts
--339.69K
--135.88K
--339.69K
--135.88K
----
----
----
----
----
----
Salaries payable
20.20%218.16M
18.95%189.35M
9.76%156.96M
7.55%224.37M
-2.44%181.49M
0.64%159.18M
-0.22%143.01M
1.41%208.62M
23.17%186.02M
19.17%158.16M
Taxs payable
16.25%73.57M
-31.33%55.18M
-34.86%42.62M
-42.44%39.64M
-29.99%63.29M
61.64%80.36M
-32.96%65.44M
9.37%68.88M
-8.71%90.4M
41.59%49.72M
Other payable (including interest and dividends)
62.85%447.44M
57.58%738.09M
1.69%357.72M
-37.50%279.03M
-22.76%274.76M
-49.09%468.38M
-51.77%351.78M
16.53%446.49M
-24.22%355.73M
157.17%920.09M
-Dividend payable
----
193,359.27%317.64M
----
----
----
-99.94%164.19K
--190.49K
18.49%653K
--551.12K
--254.66M
-Other payable
----
-10.20%420.45M
----
----
----
-29.64%468.22M
----
16.53%445.83M
----
85.99%665.42M
Non current liabilities due within one year
-8.78%13.26M
11.02%13.21M
19.12%12.77M
-4.69%10.93M
14.93%14.54M
86.42%11.9M
54.71%10.72M
64.10%11.46M
--12.65M
-36.76%6.38M
Other current liabilities
8.15%35.23M
-26.14%35.74M
-91.66%35.77M
-91.67%35.55M
-91.16%32.58M
4,662.86%48.4M
37,041.48%428.98M
7,876.93%426.82M
28,108.07%368.38M
258.55%1.02M
Total current liabilities
8.16%1.01B
7.05%1.23B
-38.55%810.68M
-49.17%815.08M
-36.43%934.71M
-29.79%1.15B
-7.80%1.32B
58.33%1.6B
30.07%1.47B
68.48%1.63B
Current liabilities
Estimate liabilities
----
----
----
----
----
----
----
----
--55.66M
--61.5M
Deferred tax liabilities
-13.13%21.92M
-12.87%22.27M
-55.63%11.71M
-52.04%13.04M
--25.24M
--25.56M
--26.39M
--27.18M
----
----
Long term deferred income
31.90%121.22M
-14.14%90.57M
9.82%98.84M
-14.64%84.11M
-13.46%91.9M
-5.01%105.48M
-14.70%90M
5.14%98.53M
8.50%106.2M
13.39%111.05M
Lease liabilities
-75.98%5.14M
-69.88%4.96M
-58.71%8.07M
-35.97%12.54M
-26.23%21.39M
149.12%16.46M
157.88%19.55M
114.90%19.58M
101.22%29M
-46.57%6.61M
Other non current liabilities
4.25%428.64M
3.91%423.65M
1,343.29%418.51M
1,305.05%416.47M
1,287.24%411.18M
1,282.95%407.7M
-2.14%29M
-2.13%29.64M
21.26%29.64M
20.60%29.48M
Total non current liabilities
4.95%576.92M
-2.48%541.45M
225.66%537.12M
200.77%526.16M
149.30%549.71M
166.12%555.2M
-22.20%164.93M
-5.64%174.94M
42.10%220.5M
-12.58%208.63M
Total liabilities
6.97%1.59B
3.94%1.77B
-9.19%1.35B
-24.59%1.34B
-12.20%1.48B
-7.59%1.7B
-9.66%1.48B
48.43%1.78B
31.52%1.69B
52.46%1.84B
Shareholders equity
Paid-in capital
0.00%1.11B
0.00%1.11B
0.00%1.11B
0.00%1.11B
0.00%1.11B
0.00%1.11B
0.00%1.11B
0.00%1.11B
0.00%1.11B
0.00%1.11B
Capital reserve funds
2.23%1.93B
1.87%1.91B
1.83%1.91B
1.86%1.9B
2.66%1.89B
-1.44%1.88B
-2.88%1.87B
-3.35%1.87B
-4.51%1.84B
-0.89%1.91B
Surplus reserve funds
0.00%526.36M
0.00%526.36M
0.00%526.36M
0.00%526.36M
0.00%526.36M
0.00%526.36M
0.00%526.36M
0.00%526.36M
6.99%526.36M
6.99%526.36M
Retained profit
1.32%5B
0.85%4.84B
0.45%5.24B
0.69%5.04B
0.63%4.94B
1.71%4.79B
3.43%5.21B
4.15%5B
5.34%4.91B
3.88%4.71B
Less:Treasury stock
----
0.00%602.16M
0.00%602.16M
0.00%602.16M
0.00%602.16M
0.00%602.16M
9.42%602.16M
83.67%602.16M
156.71%602.16M
--602.16M
Other composite income
-25.68%36.15M
-13.08%45.07M
68.30%42.82M
27.01%42.22M
20.93%48.64M
385.49%51.85M
249.20%25.44M
347.86%33.24M
3,386.20%40.22M
600.27%10.68M
Shareholders equity without minority interests
8.81%8.61B
0.89%7.83B
0.92%8.23B
0.98%8.02B
1.13%7.91B
1.23%7.77B
1.35%8.15B
-1.16%7.94B
-1.66%7.82B
-4.91%7.67B
Minority interests
7.34%37.97M
3.78%36.73M
1.92%35.87M
1.73%36.43M
145.86%35.37M
303.35%35.39M
197.42%35.19M
200.67%35.81M
14.57%14.39M
-88.95%8.77M
Total shareholder equity
8.80%8.64B
0.91%7.87B
0.93%8.26B
0.99%8.06B
1.39%7.95B
1.58%7.8B
1.63%8.19B
-0.86%7.98B
-1.64%7.84B
-5.73%7.68B
Total liabilityies and equity
8.51%10.23B
1.45%9.64B
-0.63%9.61B
-3.68%9.4B
-1.02%9.43B
-0.20%9.5B
-0.28%9.67B
5.53%9.76B
2.97%9.53B
1.79%9.52B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Daxin Certified Public Accountants (Special General Partnership)
--
--
--
Daxin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds -42.31%1.03B-50.61%938.24M-39.24%1.41B-50.50%1.32B-44.64%1.78B-46.00%1.9B-31.83%2.33B-17.47%2.67B-2.66%3.22B3.08%3.52B
Transactional financial assets 195.70%667.58M158.10%533.82M-58.29%180.74M-43.34%186.06M220.71%225.76M588.52%206.83M377.85%433.29M447.27%328.36M75.51%70.39M24.94%30.04M
Notes receivable and accounts receivable 5.94%485.36M-12.89%534.68M-15.69%470.27M-6.51%467.4M-13.39%458.15M21.91%613.78M17.32%557.77M25.59%499.97M4.56%529M-2.59%503.49M
-Notes receivable ---------------------------------87.33%8.49M-78.71%12.72M
-Accounts receivable 5.94%485.36M-12.89%534.68M-15.69%470.27M-6.51%467.4M-11.98%458.15M25.07%613.78M18.68%557.77M26.39%499.97M18.58%520.52M7.36%490.76M
Other receivables (including interest and dividends) 63.53%33.35M65.65%31M28.08%29.08M-10.24%21.01M21.99%20.4M30.31%18.71M-84.86%22.71M-84.95%23.4M-21.98%16.72M-42.78%14.36M
-Other receivable ----65.65%31M------------30.31%18.71M-----84.95%23.4M-----42.78%14.36M
Advance payment 98.19%43.72M-36.99%27.46M62.52%54.55M-23.46%26.13M-18.03%22.06M86.22%43.59M33.86%33.56M157.65%34.13M11.34%26.91M-29.92%23.41M
Inventories 3.10%487.88M-3.53%471.82M-13.16%457.28M-9.69%490.86M1.92%473.19M-0.98%489.06M16.28%526.58M29.27%543.53M22.13%464.29M19.28%493.9M
Receivable financing -11.08%111.2M17.06%85.75M59.81%179.45M35.05%77.98M55.28%125.06M233.13%73.25M-13.34%112.29M-23.94%57.74M--80.54M--21.99M
Assets held for sale ----------------0.00%11.73M0.00%11.73M0.00%11.73M0.00%11.73M-91.94%11.73M-91.93%11.73M
Non-current assets due within one year --214.76M------164.61M--163.33M------------------------
Other current assets 19.26%689.37M21.28%689.85M0.38%548.62M3.03%558.49M1,848.23%578.06M3,097.45%568.82M1,507.73%546.53M1,541.84%542.07M-52.63%29.67M-70.63%17.79M
Total current assets 1.76%3.76B-15.61%3.31B-23.47%3.5B-29.68%3.31B-16.89%3.7B-15.31%3.93B-4.42%4.57B6.98%4.71B-0.86%4.45B0.05%4.64B
Non Current assets
Other equity investment 12.78%264.8M0.00%234.8M0.00%234.8M17.40%234.8M17.40%234.8M17.40%234.8M17.40%234.8M0.00%200M0.00%200M0.00%200M
Other non-current financial assets -0.73%276.08M21.46%277.43M22.75%276.41M22.07%276.38M21.30%278.1M1.19%228.41M1.13%225.18M1.48%226.42M4.83%229.27M3.24%225.72M
Investment real estate -9.82%32.49M-1.71%32.9M11.28%35.19M-6.87%32.35M-17.89%36.03M-5.58%33.48M-5.55%31.62M21.38%34.73M52.66%43.88M29.00%35.46M
Long-term equity investment -0.29%282.64M-4.02%280.44M-3.54%283.97M-2.35%290.74M2.66%283.46M5.43%292.18M5.63%294.39M6.83%297.73M18.51%276.11M7.87%277.12M
Fixed assets -----2.08%1.37B-------------5.26%1.4B-----5.79%1.44B----22.60%1.48B
Constru in process -----15.62%50.62M------------31.95%59.99M-----60.06%37.6M-----88.23%45.47M
Intangible assets 4.81%1.42B-8.88%1.26B36.52%1.26B36.52%1.32B37.59%1.35B40.18%1.39B-6.92%922.9M-7.92%965.46M-19.04%982.45M-19.30%988.38M
Development expenditure 25.22%1.44B43.57%1.5B6.46%1.39B6.45%1.3B-3.76%1.15B-5.59%1.04B18.73%1.31B26.65%1.22B31.77%1.2B26.70%1.1B
Goodwill -81.97%10.91M-81.97%10.91M-81.97%10.91M-81.97%10.91M-30.54%60.53M-30.54%60.53M-30.54%60.53M-30.54%60.53M0.00%87.14M0.00%87.14M
Long deferred expense -3.22%105.7M-7.38%104.1M-4.56%112.34M-5.43%117.98M-12.77%109.22M-13.95%112.39M-10.92%117.71M47.50%124.75M35.01%125.2M66.47%130.61M
Deferred tax assets 78.07%131.42M31.51%116.2M7.41%93.96M-1.15%87.4M-9.10%73.8M5.65%88.36M-6.01%87.48M7.81%88.42M15.36%81.19M41.45%83.63M
Usufruct assets -43.31%18.85M-40.77%14.91M-31.86%18.11M-28.91%20.83M-19.13%33.25M99.25%25.18M84.70%26.58M81.29%29.3M191.54%41.11M-0.65%12.64M
Other non current assets 61.77%1.07B75.33%1.08B195.32%960.37M199.12%959.68M112.97%661.84M181.82%613.21M58.12%325.2M54.89%320.83M353.47%310.77M135.30%217.59M
Total non current assets 12.86%6.47B13.46%6.33B19.85%6.11B20.61%6.08B12.87%5.73B14.14%5.58B3.75%5.1B4.21%5.04B6.58%5.08B3.49%4.89B
Total assets 8.51%10.23B1.45%9.64B-0.63%9.61B-3.68%9.4B-1.02%9.43B-0.20%9.5B-0.28%9.67B5.53%9.76B2.97%9.53B1.79%9.52B
Liabilities
Current liabilities
Short term loan -68.36%60M-94.88%10M-83.48%10M-77.42%40M18.44%189.61M-14.51%195.38M-66.43%60.55M181.25%177.19M38.58%160.09M-0.72%228.54M
Transactional financial liabilities --------------------------2.21M--1.87M--------
Notes payable and accounts payable 1.78%131.24M6.02%145.72M-19.69%163.24M-28.97%156.01M-38.86%128.94M-27.02%137.44M1.04%203.26M17.04%219.65M2.94%210.91M42.47%188.32M
-Notes payable --------------------------35.31M--33.57M--40M----
-Accounts payable 1.78%131.24M6.02%145.72M-2.80%163.24M-16.16%156.01M-24.55%128.94M-27.02%137.44M-16.51%167.95M-0.85%186.08M-16.58%170.91M42.47%188.32M
Contract liabilities -35.79%31.78M-12.34%39.79M-41.46%31.26M-31.06%29.41M-42.51%49.5M-43.67%45.39M-24.81%53.4M-56.46%42.66M-3.47%86.09M13.83%80.58M
Advance receipts --339.69K--135.88K--339.69K--135.88K------------------------
Salaries payable 20.20%218.16M18.95%189.35M9.76%156.96M7.55%224.37M-2.44%181.49M0.64%159.18M-0.22%143.01M1.41%208.62M23.17%186.02M19.17%158.16M
Taxs payable 16.25%73.57M-31.33%55.18M-34.86%42.62M-42.44%39.64M-29.99%63.29M61.64%80.36M-32.96%65.44M9.37%68.88M-8.71%90.4M41.59%49.72M
Other payable (including interest and dividends) 62.85%447.44M57.58%738.09M1.69%357.72M-37.50%279.03M-22.76%274.76M-49.09%468.38M-51.77%351.78M16.53%446.49M-24.22%355.73M157.17%920.09M
-Dividend payable ----193,359.27%317.64M-------------99.94%164.19K--190.49K18.49%653K--551.12K--254.66M
-Other payable -----10.20%420.45M-------------29.64%468.22M----16.53%445.83M----85.99%665.42M
Non current liabilities due within one year -8.78%13.26M11.02%13.21M19.12%12.77M-4.69%10.93M14.93%14.54M86.42%11.9M54.71%10.72M64.10%11.46M--12.65M-36.76%6.38M
Other current liabilities 8.15%35.23M-26.14%35.74M-91.66%35.77M-91.67%35.55M-91.16%32.58M4,662.86%48.4M37,041.48%428.98M7,876.93%426.82M28,108.07%368.38M258.55%1.02M
Total current liabilities 8.16%1.01B7.05%1.23B-38.55%810.68M-49.17%815.08M-36.43%934.71M-29.79%1.15B-7.80%1.32B58.33%1.6B30.07%1.47B68.48%1.63B
Current liabilities
Estimate liabilities ----------------------------------55.66M--61.5M
Deferred tax liabilities -13.13%21.92M-12.87%22.27M-55.63%11.71M-52.04%13.04M--25.24M--25.56M--26.39M--27.18M--------
Long term deferred income 31.90%121.22M-14.14%90.57M9.82%98.84M-14.64%84.11M-13.46%91.9M-5.01%105.48M-14.70%90M5.14%98.53M8.50%106.2M13.39%111.05M
Lease liabilities -75.98%5.14M-69.88%4.96M-58.71%8.07M-35.97%12.54M-26.23%21.39M149.12%16.46M157.88%19.55M114.90%19.58M101.22%29M-46.57%6.61M
Other non current liabilities 4.25%428.64M3.91%423.65M1,343.29%418.51M1,305.05%416.47M1,287.24%411.18M1,282.95%407.7M-2.14%29M-2.13%29.64M21.26%29.64M20.60%29.48M
Total non current liabilities 4.95%576.92M-2.48%541.45M225.66%537.12M200.77%526.16M149.30%549.71M166.12%555.2M-22.20%164.93M-5.64%174.94M42.10%220.5M-12.58%208.63M
Total liabilities 6.97%1.59B3.94%1.77B-9.19%1.35B-24.59%1.34B-12.20%1.48B-7.59%1.7B-9.66%1.48B48.43%1.78B31.52%1.69B52.46%1.84B
Shareholders equity
Paid-in capital 0.00%1.11B0.00%1.11B0.00%1.11B0.00%1.11B0.00%1.11B0.00%1.11B0.00%1.11B0.00%1.11B0.00%1.11B0.00%1.11B
Capital reserve funds 2.23%1.93B1.87%1.91B1.83%1.91B1.86%1.9B2.66%1.89B-1.44%1.88B-2.88%1.87B-3.35%1.87B-4.51%1.84B-0.89%1.91B
Surplus reserve funds 0.00%526.36M0.00%526.36M0.00%526.36M0.00%526.36M0.00%526.36M0.00%526.36M0.00%526.36M0.00%526.36M6.99%526.36M6.99%526.36M
Retained profit 1.32%5B0.85%4.84B0.45%5.24B0.69%5.04B0.63%4.94B1.71%4.79B3.43%5.21B4.15%5B5.34%4.91B3.88%4.71B
Less:Treasury stock ----0.00%602.16M0.00%602.16M0.00%602.16M0.00%602.16M0.00%602.16M9.42%602.16M83.67%602.16M156.71%602.16M--602.16M
Other composite income -25.68%36.15M-13.08%45.07M68.30%42.82M27.01%42.22M20.93%48.64M385.49%51.85M249.20%25.44M347.86%33.24M3,386.20%40.22M600.27%10.68M
Shareholders equity without minority interests 8.81%8.61B0.89%7.83B0.92%8.23B0.98%8.02B1.13%7.91B1.23%7.77B1.35%8.15B-1.16%7.94B-1.66%7.82B-4.91%7.67B
Minority interests 7.34%37.97M3.78%36.73M1.92%35.87M1.73%36.43M145.86%35.37M303.35%35.39M197.42%35.19M200.67%35.81M14.57%14.39M-88.95%8.77M
Total shareholder equity 8.80%8.64B0.91%7.87B0.93%8.26B0.99%8.06B1.39%7.95B1.58%7.8B1.63%8.19B-0.86%7.98B-1.64%7.84B-5.73%7.68B
Total liabilityies and equity 8.51%10.23B1.45%9.64B-0.63%9.61B-3.68%9.4B-1.02%9.43B-0.20%9.5B-0.28%9.67B5.53%9.76B2.97%9.53B1.79%9.52B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Daxin Certified Public Accountants (Special General Partnership)------Daxin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Monoclonal Antibody Concept
Monoclonal Antibody Concept
Intraday-1.90%